Rep. Thomas H. Kean Jr discloses trade(s) in ABT, GM, JNJ, MKL, MSFT
Thomas H. Kean Jr (NJ07) disclosed 6 transactions, traded Jan 7 – Jan 29: 1 purchase and 5 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jan 29 | ABT | Abbott Laboratories | Buy | $1,001 - $15,000 | Self |
| Jan 23 | JNJ | Kean Family Partnership Johnson & Johnson | Sell (partial) | $15,001 - $50,000 | Self |
| Jan 23 | MKL | State Street Bank & Trust Co. Markel Group Inc. | Sell (partial) | $15,001 - $50,000 | Self |
| Jan 23 | MSFT | State Street Bank & Trust Co. Microsoft Corporation | Sell (partial) | $1,001 - $15,000 | Self |
| Jan 23 | SYK | State Street Bank & Trust Co. Stryker Corporation | Sell (partial) | $15,001 - $50,000 | Self |
| Jan 7 | GM | Kean Family Partnership General Motors Company | Sell | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY THOMAS H. KEAN JR →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member filed required disclosures covering equity transactions in five companies spanning healthcare, automotive, and technology sectors. Congressional stock trading disclosures are public record under the STOCK Act and related transparency rules, allowing tracking of lawmakers' personal investment activity. Such disclosures can signal confidence or hedging in specific sectors and are monitored for potential conflicts of interest or insider information concerns.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Thomas H. Kean JrSep 29, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 29
Resolved
LIKELYThis disclosure is a routine filing with no inherent market consequence; the trades themselves occurred weeks prior and were already reflected in market prices, so formal notification typically produces no measurable price movement.
Status quo
LIKELYThe filing remains a matter of public record but generates no media attention or legislative scrutiny, leaving sentiment and positioning in these large-cap stocks unaffected by the disclosure event itself.
Worsens
UNLIKELYIf the pattern or timing of these trades (notably the concentration of sales on 01/23/2026 across JNJ, MKL, MSFT, and SYK) triggers media or watchdog scrutiny around potential insider information or coordination, reputational pressure on the representative could theoretically amplify broader concerns about congressional trading practices, though direct stock-price impact would remain indirect and diffuse.
SPONSORED
More on Congressional Stock Trading
- Rep. James A. Himes files a Periodic Transaction ReportOct 20
- Rep. Jonathan Jackson discloses trade(s) in DDOG, EL, GH, TYG, VSATOct 19
- Rep. Michael Rulli discloses trade(s) in GOOG, WSBCOct 19
- Attorneys for Ilhan Omar seek return of items taken during home searchOct 17
- Rep. Laurel Lee discloses trade(s) in BAC, NOKBFOct 16
- Rep. Scott H. Peters files a Periodic Transaction ReportOct 15
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.